GL1X · GenesisL1 explorer

MolNFT v1 · #178600 · protein

Human gar transformylase in complex with gar substrate and AGF103 inhibitor

7JG3 · Trifunctional purine biosynthetic protein adenosine-3: “Human gar transformylase in complex with gar substrate and AGF103 inhibitor”. X-ray diffraction, 3 ligands (GAR, V9A, NA), 1 pocket (best druggability 0.65). MolNFT v1 #178600…

PDB
7JG3
Type
protein
Length
200 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Trifunctional purine biosynthetic protein adenosine-3
EC
6.3.4.13, 6.3.3.1, 2.1.2.2
UniProt
P22102
Ligands
GAR, V9A, NA
Pockets
1 · best druggability 0.65

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATrifunctional purine biosynthetic protein adenosine-3 (EC 6.3.4.13, 6.3.3.1, 2.1.2.2)protein20037% helix, 24% strandP22102

Ligands and binding sites

  • GAR · Glycinamide ribonucleotide · ligand · chains A
  • V9A · N-{5-[4-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl]furan-2-carbonyl}-L-glutamic acid · ligand · chains A
  • NA · Sodium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13200.650.8140GAR, V9A

Compared structures

  • 7JG3 · Human GAR transformylase in complex with GAR substrate and AGF103 inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P22102 · AlphaFold monomer V2.0 prediction for trifunctional purine biosynthetic protein… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.